MolScanner

Molscanner is the CDMO division of Chemical.AI, specializing in the research, production, and process development and optimization of building blocks (also known as pharmaceutical intermediates). With 17 years of experience in the chemical industry and over 10 years in molecular R&D and manufacturing, we have developed more than 3,000 building blocks to date, covering a wide range of molecular scaffolds. We have also published over 10 innovative patents related to molecular synthesis. Our building blocks are widely used in the development of drugs targeting various therapeutic areas, including oncology, neurological disorders, immune system diseases, infectious diseases, cardiovascular diseases, and endocrine and metabolic disorders. We offer specialized categories of building blocks, such as PROTAC linkers and E3 ligase ligands, ADC linkers and cytotoxin precursors, fluorinated and iodinated building blocks, aliphatic/aromatic (hetero) cyclic compounds, peptide drug fragments, and nucleoside/nucleotide drug fragments. In addition, we have established an automated high-throughput reaction platform integrated with an AI retrosynthesis algorithm analysis platform. This combination increases the number of reaction condition explorations and reactions that can be performed by a single researcher per day by 24 to 43 times. This new chemical synthesis model is particularly well-suited for batch synthesis of high-value building blocks.

• (2S,4R)-1-((S)-2-Amino-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide